With the support of the National Institute on Drug Abuse, scientists at Wake Forest School of Medicine have been working to find a safe, non-addictive pain killer to help fight the current opioid crisis in this country.
And they may have done just that, though in an animal model.
Known as AT-121, the new chemical compound has dual therapeutic action that suppressed the addictive effects of opioids and produced morphine-like analgesic effects in non-human primates.
“In our study, we found AT-121 to be safe and non-addictive, as well as an effective pain medication,” said Mei-Chuan Ko, Ph.D., professor of physiology and pharmacology at the School of Medicine, part of Wake Forest Baptist Medical Center.
“In addition, this compound also was effective at blocking abuse potential of prescription opioids, much like buprenorphine does for heroin, so we hope it could be used to treat pain and opioid abuse.”
The findings are published in the Aug. 29 issue of the journal Science Translational Medicine.
The main objective of this study was to design and test a chemical compound that would work on both the mu opioid receptor, the main component in the most effective prescription pain killers, and the nociceptin receptor, which opposes or blocks the abuse and dependence-related side effects of mu-targeted opioids. Current opioid pain drugs, such as fentanyl and oxycodone, work only on the mu opioid receptor, which also produces unwanted side effects – respiratory depression, abuse potential, increased sensitivity to pain and physical dependence.
“We developed AT-121 that combines both activities in an appropriate balance in one single molecule, which we think is a better pharmaceutical strategy than to have two drugs to be used in combination,” Ko said.
In the study, the researchers observed that AT-121 showed the same level of pain relief as an opioid, but at a 100-times lower dose than morphine. At that dose, it also blunted the addictive effects of oxycodone, a commonly abused prescription drug.
The bifunctional profile of AT-121 not only gave effective pain relief without abuse potential, it also lacked other opioid side-effects that patients typically struggle with, such as itch, respiratory depression, tolerance and dependence.
“Our data shows that targeting the nociceptin opioid receptor not only dialed down the addictive and other side-effects, it provided effective pain relief,” Ko said. “The fact that this data was in nonhuman primates, a closely related species to humans, was also significant because it showed that compounds, such as AT-121, have the translational potential to be a viable opioid alternative or replacement for prescription opioids.”
Next steps include conducting additional preclinical studies to collect more safety data, and then if all goes well, applying to the Food and Drug Administration for approval to begin clinical trials in people, Ko said.
Learn more: Scientists Take Big Step Toward Finding Non-Addictive Pain Killer
The Latest on: Non-addictive pain killer
[google_news title=”” keyword=”non-addictive pain killer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Non-addictive pain killer
- New Technique Visualizes Stress Buildup in Gas Turbine Coatingson April 26, 2024 at 9:46 am
In a recent paper published in the Journal of Advanced Ceramics, a group of material scientists from Kunming University of Science and Technology have developed a high-throughput multiscale evaluation ...
- Traffic Road Marking Coatings Market Poised to Reach US$ 9.34 Billion by 2032, Fueled by Innovations in Reflectivity and Durabilityon April 26, 2024 at 8:07 am
The global traffic road marking coatings market sales are expected to reach a market valuation of US$ 5.22 Billion by the year 2022, accelerating with a moderate CAGR of 6% by 2022-2032. The Traffic ...
- Pipe Coating Materials Market Size to Worth $15.3 Billion by 2032 | CAGR: 4.3%: AMRon April 26, 2024 at 7:16 am
Pipe coating materials play a vital role in protecting pipelines from corrosion caused by environmental factors, chemicals, and abrasion. With growing awareness about the importance of corrosion ...
- CATL’s New LFP Battery Unlocks 373-Mile Range With 10-Minute Chargeon April 25, 2024 at 5:00 pm
The company’s latest battery uses advanced lithium-iron phosphate with a proprietary 3D honeycomb-shaped material added to the anode ... CATL is using a new lithium-ion conductive coating and has ...
- Researchers establish a high-throughput multiscale evaluation method for thermal stress in thermal barrier coatingson April 25, 2024 at 1:35 pm
Thermal barrier coatings (TBCs) are widely used in gas turbine engines to obtain elevated working temperatures and improve engine efficiency. The phase transition of the ceramic layer is accompanied ...
- Cold Gas Spray Coating Market: Driving Sustainability and Innovation in Automotive, Aerospace, and Beyondon April 25, 2024 at 2:54 am
In 2023, the cold gas spray coating market is expected to be worth US$ 1.1 billion. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2033, reaching US$ 1.6 billion. For the automotive ...
- Axalta Wins Three Edison Awards for Innovation in Coatings and Environmental Solutionson April 24, 2024 at 9:00 pm
Axalta Coating Systems (NYSE: AXTA) announced its receipt of three awards at the 2024 Edison Awards™, marking the company’s sixth consecutive year of recognition for its innovations. Axalta garnered ...
- Crinkled coatings could prevent medical implants from failingon April 24, 2024 at 8:03 am
Medical implants could fail less often when coated with a microscopically crinkled, ceramic material designed by researchers at the University of Michigan. The coating is described in a paper ...
- Novel graphene oxide spray coating advances antiviral protection of face maskson April 22, 2024 at 9:57 am
In the relentless battle against airborne viruses, researchers have developed a new spray coating to improve the antiviral efficacy of personal protective equipment, notably face masks. The study is ...
- New window coating blocks heat at all angleson April 19, 2024 at 3:06 am
A team of researchers from the University of Notre Dame has developed a new window coating that blocks heat-generating ultraviolet (UV) and infrared light, while letting through visible light, no ...
via Bing News